Arrowhead Pharmaceuticals (ARWR) Other Operating Expenses (2010 - 2026)
Arrowhead Pharmaceuticals' (ARWR) quarterly Other Operating Expenses came in at $19.0 million in Q1 2026, up 140.93% on a QoQ basis from $7.9 million in Q4 2016.
Powered by 
Analysis
Arrowhead Pharmaceuticals (ARWR) Other Operating Expenses (2010 - 2026) Analysis & Trends
Arrowhead Pharmaceuticals (ARWR) has 8 years of Other Operating Expenses data on file, last reported at $19.0 million in Q1 2026.
- Quarterly Other Operating Expenses changed N/A year-over-year to $19.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.0 million (changed N/A YoY) and the FY2016 annual result came in at -$3.8 million, down 19957.5% from the prior year.
- Other Operating Expenses improved to $19.0 million in Q1 2026, from $7.9 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $19.0 million in Q1 2026 to a low of $19.0 million in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Arrowhead Pharmaceuticals | 12.40 Bn | 10.80 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 19.00 Mn |
| Dec 31, 2016 | 7.89 Mn |
| Sep 30, 2016 | -26.06 Mn |
| Jun 30, 2016 | 7.68 Mn |
| Mar 31, 2016 | 7.47 Mn |
| Dec 31, 2015 | 7.09 Mn |
| Mar 31, 2015 | 45,576.00 |
| Dec 31, 2014 | -26,381.00 |
| Mar 31, 2014 | -5,316.00 |
| Dec 31, 2013 | -53,562.00 |
| Jun 30, 2013 | -39,949.00 |
| Mar 31, 2013 | -54,932.00 |
| Dec 31, 2012 | 18,493.00 |
| Sep 30, 2012 | -169,616.00 |
| Jun 30, 2012 | -876,277.00 |
| Mar 31, 2012 | -33,484.00 |
| Dec 31, 2011 | 2.03 Mn |
| Sep 30, 2011 | 705,244.00 |
| Jun 30, 2011 | 761,382.00 |
| Mar 31, 2011 | 855,506.00 |